Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial

By sjmartinez • February 11, 2023

Boulware DR, Murray TA, Proper JL, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Siegel LK, Klatt NR, Odde DJ, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Sherwood NE, Huling JD, Bramante CT; COVID-OUT study team. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial. Clin Infect Dis. 2023 Feb 8;76(3):e1-e9. doi: 10.1093/cid/ciac772. PMID: 36124697; PMCID: PMC9494422.

Tags: covid-19, General Internal Medicine, Olive View DoM, Publications, SARS-CoV-2, Symptoms, vaccine

Adherence to pro-vegetarian dietary patterns and gastric cancer risk: a pooled analysis of the StoP Consortium

Oncina-Cánovas A, Torres-Collado L, García-de-la-Hera M, González-Palacios S, Ojeda-Belokon C, Negri E, Pelucchi C, Lagiou A, Lagiou P, Lunet N, Morais S, Martin V, Castaño-Vinyals[...]

False negative rate of direct immunofluorescence in bullous pemphigoid does not significantly differ by anatomic site

Thompson BB, Reardon RM, Lin C, Yan MJ, Corey S, Hoang MP, Chen ST. False negative rate of direct immunofluorescence in bullous pemphigoid does not[...]

Implementation of a Hospital-Based Screening and Treatment Program for Unhealthy Alcohol Use

Ramesh J, Moriates C, Embers J, Boulton A, Kluz N, Holliman R, Ibarra F, Dede-Bamfo O, Chang P, Velasquez M, Pignone M. Implementation of a[...]